Suppr超能文献

光破坏基质成纤维细胞增强三维胰腺癌共培养模型中 PDT 的肿瘤反应。

Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.

机构信息

Department of Physics, University of Massachusetts at Boston, Boston, MA, USA.

Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Photochem Photobiol. 2021 Mar;97(2):416-426. doi: 10.1111/php.13339. Epub 2020 Oct 27.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal of human cancers. The dismal response of PDAC to virtually all therapeutics is associated, in part, with a characteristically dense fibrotic stroma. This stroma not only acts as a barrier to drug perfusion, but also promotes tumor survival through paracrine crosstalk and biophysical interactions. Photodynamic therapy (PDT) is being explored for PDAC treatment, though the impact of tumor-promoting stromal crosstalk on PDT response in PDAC is not well-characterized. The current study assesses the effect of tumor-stroma interactions on response to PDT or chemotherapy in heterocellular 3D cocultures using PDAC cells and two different fibroblastic cell types (pancreatic stellate cells, PSCs, and a normal human fibroblast cell line, MRC5) embedded in extracellular matrix (ECM). While stromal fibroblasts promote resistance to chemotherapy as expected, PDAC 3D nodules in coculture with fibroblasts exhibit increased response to PDT relative to homotypic cultures. These results point to the potential for PDT to overcome tumor-promoting stromal interactions associated with poor therapeutic response in PDAC.

摘要

胰腺导管腺癌 (PDAC) 是人类癌症中最致命的癌症之一。PDAC 对几乎所有治疗方法的反应都很差,部分原因是其特有的致密纤维性基质。这种基质不仅作为药物灌注的屏障,而且还通过旁分泌串扰和生物物理相互作用促进肿瘤存活。光动力疗法 (PDT) 正在被探索用于治疗 PDAC,尽管肿瘤促进性基质串扰对 PDAC 中 PDT 反应的影响尚未得到很好的描述。本研究使用 PDAC 细胞和两种不同的成纤维细胞类型(胰腺星状细胞,PSC 和正常人类成纤维细胞系 MRC5)在细胞外基质 (ECM) 中嵌入异细胞 3D 共培养物中,评估肿瘤-基质相互作用对 PDT 或化疗反应的影响。虽然基质成纤维细胞如预期的那样促进对化疗的耐药性,但与成纤维细胞共培养的 PDAC 3D 结节对 PDT 的反应相对于同型培养物增加。这些结果表明 PDT 有可能克服与 PDAC 治疗反应差相关的肿瘤促进性基质相互作用。

相似文献

1
Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.
Photochem Photobiol. 2021 Mar;97(2):416-426. doi: 10.1111/php.13339. Epub 2020 Oct 27.
3
Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
Mol Pharm. 2022 Jul 4;19(7):2549-2563. doi: 10.1021/acs.molpharmaceut.2c00260. Epub 2022 May 18.
5
Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models.
Photochem Photobiol. 2023 Jan;99(1):120-131. doi: 10.1111/php.13663. Epub 2022 Aug 3.
6
Generation of an in vitro 3D PDAC stroma rich spheroid model.
Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2.
7
Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Theranostics. 2021 Jan 1;11(5):2182-2200. doi: 10.7150/thno.53102. eCollection 2021.
8
Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Gastroenterology. 2018 Apr;154(5):1524-1537.e6. doi: 10.1053/j.gastro.2017.12.014. Epub 2017 Dec 21.
10
Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.
Acta Biomater. 2018 Feb;67:331-340. doi: 10.1016/j.actbio.2017.11.037. Epub 2017 Dec 2.

引用本文的文献

2
Engineering photodynamics for treatment, priming and imaging.
Nat Rev Bioeng. 2024 Sep;2(9):752-769. doi: 10.1038/s44222-024-00196-z. Epub 2024 Jun 19.
4
PD-L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self-Delivery.
Adv Healthc Mater. 2024 Jul;13(19):e2304340. doi: 10.1002/adhm.202304340. Epub 2024 Mar 14.
5
Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma.
Cancers (Basel). 2023 Aug 16;15(16):4135. doi: 10.3390/cancers15164135.
6
Immune checkpoint blockade enhances chemophototherapy in a syngeneic pancreatic tumor model.
APL Bioeng. 2022 Sep 23;6(3):036105. doi: 10.1063/5.0099811. eCollection 2022 Sep.
7
Tissue Engineering and Photodynamic Therapy: A New Frontier of Science for Clinical Application -An Up-To-Date Review.
Front Bioeng Biotechnol. 2022 Jun 15;10:837693. doi: 10.3389/fbioe.2022.837693. eCollection 2022.
8
Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models.
Photochem Photobiol. 2023 Jan;99(1):120-131. doi: 10.1111/php.13663. Epub 2022 Aug 3.
9
Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
Mol Pharm. 2022 Jul 4;19(7):2549-2563. doi: 10.1021/acs.molpharmaceut.2c00260. Epub 2022 May 18.
10
Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma.
Cancers (Basel). 2021 Aug 28;13(17):4354. doi: 10.3390/cancers13174354.

本文引用的文献

1
Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy.
Mol Cancer Ther. 2020 Jun;19(6):1308-1319. doi: 10.1158/1535-7163.MCT-19-0791. Epub 2020 Mar 27.
2
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.
Photochem Photobiol. 2020 Mar;96(2):232-259. doi: 10.1111/php.13209. Epub 2020 Mar 5.
5
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma.
Cell Rep. 2018 Nov 13;25(7):1741-1755.e7. doi: 10.1016/j.celrep.2018.10.051.
6
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma.
Cancer Discov. 2019 Feb;9(2):282-301. doi: 10.1158/2159-8290.CD-18-0710. Epub 2018 Oct 26.
8
Role of Extracellular Matrix in Development and Cancer Progression.
Int J Mol Sci. 2018 Oct 4;19(10):3028. doi: 10.3390/ijms19103028.
9
Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer.
Gastrointest Endosc. 2019 Feb;89(2):390-398. doi: 10.1016/j.gie.2018.09.007. Epub 2018 Sep 14.
10
Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.
Oncotarget. 2018 Feb 6;9(16):13009-13022. doi: 10.18632/oncotarget.24425. eCollection 2018 Feb 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验